← Back to TRVI

Trevi Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 05/05/2026Sep 2025Filed 13/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 05/05/2026Sep 2024Filed 13/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 08/05/2025
−$18−$13−$12−$12−$10−$13−$12−$11
−$0.11−$0.09−$0.08−$0.09−$0.09−$0.13−$0.12−$0.11
157146145130118101101100

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.